Market Tracker

01/23 6:05pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

13.23
Data as of Jan 23
 -0.11 / -0.82%
Today’s Change
11.53
Today|||52-Week Range
18.48
-6.50%
Year-to-Date

Today’s Trading

Previous close13.34
Today’s open13.32
Day’s range13.04 - 13.38
Volume1,651,239
Average volume (3 months)1,404,918
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 01/23/2015

Growth & Valuation

Earnings growth (last year)-63.84%
Earnings growth (this year)-99.06%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales149.87
Price/Book24.08

Competitors

 Today’s
change
Today’s
% change
INCRINC Research Holding...-0.83-3.38%
NXTMNxStage Medical Inc+0.10+0.53%
ARIAARIAD Pharmaceutical...-0.10-1.61%
PRAHPRA Health Sciences ...-1.13-4.15%
Data as of 4:00pm ET, 01/23/2015

Financials

Next reporting dateMarch 10, 2015
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$7.0M
Annual profit (last year)-$46.7M
Net profit margin-667.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald Bentsur
President, Chief Operating Officer &
Executive VP
Gregory P. Madison
Corporate headquarters
New York, New York

Forecasts